Results 81 to 90 of about 12,460 (212)
, 2018 Siang Fei Yeoh,1 Tae Jin Lee,2 Ka Lip Chew,3 Stephen Lin,4 Dennis Yeo,5 Sajita Setia5 1Department of Pharmacy, National University Health System, Singapore, Singapore; 2Department of Pharmacy, National University of Singapore, Singapore, Singapore ...
Yeo D +5 more
core
The problem of systemic candidosis after transplantation of solid organs. Review of the literature
Трансплантология (Москва), 2018 The article presents current views on the epidemiology, diagnosis and treatment of candidosis with organ transplantation.
S. V. Zhuravel +2 more
doaj +1 more source
Candida auris Bloodstream Infections in Russia
Antibiotics, 2020 Candida auris—a fungus (yeast) that can cause hospital outbreaks was first recognized in 2009. The authors report data on 38 cases of C. auris bloodstream infections in multidisciplinary hospitals situated in two distantly located regions of Russia ...
Natalia E. Barantsevich +4 more
doaj +1 more source
Candida Drug Resistance in Patients With Diabetic Foot Ulcers: A Systematic Review and Meta‐Analysis
International Wound Journal, Volume 23, Issue 5, May 2026.ABSTRACT Diabetic foot ulcers (DFUs) are one of the most serious and common complications that, if not treated properly, can lead to potential damage and even amputation. The aim of this systematic review and meta‐analysis was to assess the drug‐resistant Candida species in DFU.
Mohammad Hossein Ekvan +7 more
wiley +1 more source
Potential Microbiological Effects of Higher Dosing of Echinocandins.
, 2015 The antifungal "paradoxical effect" has been described as the reversal of growth inhibition at high doses of echinocandins, most usually caspofungin.
Steinbach, W.J. +2 more
core +1 more source
, 2020 International audienceWhen Candida albicans and Candida dubliniensis isolates were tested for susceptibility to fluconazole and echinocandins using either EUCAST or Etest methods, differential patterns of growth were observed, independently of the ...
Dannaoui, Eric +4 more
core +1 more source
Frontiers in Microbiology, 2019 The pathogenic yeast Candida glabrata has become a public health issue due to the increasing number of echinocandin resistant clinical strains reported.
Olga Rivero-Menendez +12 more
doaj +1 more source
Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China. [PDF]
BMC MicrobiolBackground Infections caused by Candida glabrata have raised increasing concerns, particularly due to the increasing resistance to echinocandins. Objectives This study investigated echinocandins susceptibility trends in C.
Lin W +5 more
europepmc +2 more sources
, 2015 S Grau,1 JC Pozo,2 E Romá,2 M Salavert,3 JA Barrueta,4 C Peral,4 I Rodriguez,5 D Rubio-Rodríguez,6 C Rubio-Terrés6 1Hospital del Mar (IMIM), Barcelona, 2Hospital Universitario Reina Sofía, Córdoba, 3Hospital ...
Barrueta JA +8 more
core
Echinocandins: A promising new antifungal group
, 2004 Echinocandins are a new option for fungal infections. They are fungicidal and less toxic to the host by virtue of their novel mechanism of action. They are b-1, 3-glucan synthase inhibitors.
G. Sharma, G. K. Randhawa
core